Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Year of publication: |
2013
|
---|---|
Authors: | Sanchez-de la Rosa, Rainel ; Sabater, Eliazar ; Casado, Miguel A. |
Published in: |
Health Economics Review. - Heidelberg : Springer, ISSN 2191-1991. - Vol. 3.2013, 13, p. 1-5
|
Publisher: |
Heidelberg : Springer |
Subject: | relapsing-remitting multiple sclerosis (RRMS) | cost analysis model | economic evaluation | glatiramer acetate | fingolimod |
-
Sanchez-de la Rosa, Rainel, (2013)
-
Rosa, Rainel Sanchez-de la, (2013)
-
Sánchez-de la Rosa, Rainel, (2015)
- More ...
-
Sanchez-de la Rosa, Rainel, (2013)
-
Sanchez-de la Rosa, Rainel, (2013)
-
Budgetary impact analysis of buprenorphinenaloxone combination (Suboxone®) in Spain
Martinez-Raga, Jose, (2012)
- More ...